Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MIV-150 is a nonnucleoside inhibitor of reverse transcriptase (NNRT). MIV-150 also blocking HIV-1 and HIV-2 infections (EC50<1 nM against HIV-1/HIV-2MN).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 35 days | $ 275.00 | |
1 mg | 35 days | $ 488.00 | |
5 mg | 35 days | $ 1,890.00 | |
10 mg | 35 days | $ 2,700.00 |
Description | MIV-150 is a nonnucleoside inhibitor of reverse transcriptase (NNRT). MIV-150 also blocking HIV-1 and HIV-2 infections (EC50<1 nM against HIV-1/HIV-2MN). |
Targets&IC50 | HIV-2:<1 nM (EC50), HIV-1:<1 nM (EC50) |
In vitro | MIV-150 demonstrates potent antiviral efficacy by inactivating free HIV virus with an EC50 of 0.004 μg/mL (or 0.01 μM), showcasing its high effectiveness against HIV, including strains resistant to other marketed antiretrovirals like Nevirapine, Delavirdine, and Efavirenz. Remarkably, resistance to MIV-150 develops slower compared to other anti-HIV drugs, as evident from in vitro studies where resistance to Nevirapine and Delavirdine emerged within 4 to 5 weeks, whereas resistance to MIV-150 took up to 45 weeks. Additionally, MIV-150's ability to protect target cells from infection was demonstrated through a syncytial assay, revealing an EC50 against HIV-1MN in CEM.SS cells below 1 nM, aligning with Medivir's findings. |
Synonyms | PC 815 |
Molecular Weight | 368.36 |
Formula | C19H17FN4O3 |
CAS No. | 231957-54-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MIV-150 231957-54-3 Others PC815 PC-815 PC 815 MIV 150 MIV150 inhibitor inhibit